Bretylium and dobutamine in the treatment of coronary artery disease.
D000818:Animals; D001949:Bretylium Compounds / Q000627:therapeutic use*; D001950:Bretylium Tosylate / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002395:Catecholamines / Q000627:therapeutic use*; D003327:Coronary Disease / Q000188:drug therapy*; D004280:Dobutamine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans
D001949:Bretylium Compounds; D002395:Catecholamines; D004280:Dobutamine; D001950:Bretylium Tosylate